Reactivity of Non-Td and CoStAR-Td TIL towards autologous tumor was assessed to ascertain the potential enhancement of anti-tumor activity by the CoStAR molecule against ovarian, renal and lung tumor expressing FRα (Figure 5C). This evidence concerns the gene FOLR1 and neoplasm.